Literature DB >> 21465088

[Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?].

J Hess1, S Tschirdewahn, T Szarvas, R Rossi, H Rübben, F Vom Dorp.   

Abstract

BACKGROUND: Transurethral resection of transitional cell carcinoma of the bladder provides a definitive surgical treatment and supplies tissue for histological evaluation. Superficial low-grade carcinomas with a small risk of progression are treated properly with fulguration alone. To justify fulguration as a definitive treatment of papillary bladder tumours, one must be able to safely distinguish low-grade, noninvasive tumours from those that are high grade and potentially invasive.
MATERIAL AND METHODS: A total of 160 patients with a transitional cell carcinoma at cystoscopy underwent transurethral resection of the tumour. The macroscopic appearance of the tumour, the aspect with bimanual palpation and the perioperative urine cytology were compared with the histological report.
RESULTS: In our study we were able to safely distinguish low-grade tumours from high-grade tumours. All noninvasive tumours could be identified visually as such.
CONCLUSION: Urologists skilled in the evaluation of urine cytology can distinguish low-grade noninvasive tumours of the bladder from high-grade and potentially invasive tumours by means of appearance at cystoscopy and perioperative urine cytology.

Entities:  

Mesh:

Year:  2011        PMID: 21465088     DOI: 10.1007/s00120-010-2502-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  14 in total

1.  Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.

Authors:  S J Cina; J I Epstein; J M Endrizzi; W J Harmon; T M Seay; M P Schoenberg
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

Review 2.  Guidelines on bladder cancer.

Authors:  Willem Oosterlinck; Bernard Lobel; Gerhard Jakse; Per-Uno Malmström; Michael Stöckle; Cora Sternberg
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

Review 3.  Ho:YAG-laser: treatment of vesicourethral strictures after radical prostatectomy.

Authors:  Markus J Bader; Derya Tilki; Christian Gratzke; Ronald Sroka; Christian G Stief; Oliver Reich
Journal:  World J Urol       Date:  2010-02-25       Impact factor: 4.226

Review 4.  The use of urine cytology for diagnosing bladder cancer in spinal cord injured patients.

Authors:  W H Stonehill; H B Goldman; R R Dmochowski
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

5.  Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.

Authors:  L Cheng; R M Neumann; A L Weaver; J C Cheville; B C Leibovich; D M Ramnani; B G Scherer; A Nehra; H Zincke; D G Bostwick
Journal:  Am J Clin Pathol       Date:  2000-02       Impact factor: 2.493

6.  Voided urinary cytology in bladder cancer: is it time to review the indications?

Authors:  Raghav Talwar; Tapan Sinha; S C Karan; D Doddamani; A Sandhu; G S Sethi; A Srivastava; V Narang; A Agarwal; N Adhlakha
Journal:  Urology       Date:  2007-08       Impact factor: 2.649

7.  [The value of urinary cytology in the diagnosis of high grade urothelial tumors].

Authors:  C Niedworok; V Rembrink; O W Hakenberg; C Börgermann; R Rossi; T Schneider; M Becker; T Szarvas; C von Ostau; A Swoboda; H Rübben; F vom Dorp
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

8.  Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.

Authors:  Péter Riesz; Gábor Lotz; Csilla Páska; Attila Szendrôi; Attila Majoros; Zsuzsanna Németh; Péter Törzsök; Tibor Szarvas; Ilona Kovalszky; Zsuzsa Schaff; Imre Romics; András Kiss
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

Review 9.  [Urinary cytology in cases of bladder cancer: a critical evaluation].

Authors:  P Rathert
Journal:  Urologe A       Date:  2003-03-26       Impact factor: 0.639

Review 10.  Bladder cancer: state-of-the-art care.

Authors:  M J Droller
Journal:  CA Cancer J Clin       Date:  1998 Sep-Oct       Impact factor: 508.702

View more
  8 in total

Review 1.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

Review 2.  [Photodynamic diagnostics of bladder carcinoma].

Authors:  F Vom Dorp; S Tschirdewahn; T Olbricht; T Szarvas; H Rübben
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

Review 3.  [Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?].

Authors:  M W Kramer; M Wolters; I F Abdelkawi; A S Merseburger; U Nagele; A Gross; T Bach; M A Kuczyk; T R W Herrmann
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

4.  [Visual diagnosis while performing transurethral resection of bladder tumors: power or myth?].

Authors:  S Steffens; A J Schrader; R Lehmann; H Eggers; S Ising; D Pfister; N Riechert-Mühe; A Leitenberger; A Heidenreich; W Thon; A S Merseburger; M A Kuczyk
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

Review 5.  [Diagnostics of nonmuscle-invasive urothelial cell carcinoma of the bladder].

Authors:  S Tschirdewahn; F Vom Dorp
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

Review 6.  [Intravesical therapy of non-muscle invasive bladder tumors].

Authors:  F Vom Dorp; S Tschirdewahn; G Lümmen
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

7.  [Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany].

Authors:  C Reek; M Rink; M Bloch; J Hansen; F K Chun; A Schneider; J Busche; M Fisch
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

Review 8.  Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014.

Authors:  Mario W Kramer; Mathias Wolters; Hannes Cash; Stephan Jutzi; Florian Imkamp; Markus A Kuczyk; Axel S Merseburger; Thomas R W Herrmann
Journal:  World J Urol       Date:  2014-06-17       Impact factor: 4.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.